
Michael James Haller MD
Professor and Chief, Pediatric Endocrinology, University of Florida
Join to view full profile
1600 SW Archer RdGainesville, FL 32610
Phone+1 352-265-0111
Fax+1 352-265-5420
Dr. Haller is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of FloridaFellowship, Pediatric Endocrinology, 2003 - 2006
University of FloridaResidency, Pediatrics, 2000 - 2003
University of Florida College of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2004 - 2027
NC State Medical License 2017 - 2027
American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
Publications & Presentations
PubMed
- Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.Joanna L Clasen, Berglind Jonsdottir, Kendra Vehik, Kristian F Lynch, Hemang M Parikh
American Journal of Epidemiology. 2026-08-05 - A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design.Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My-Liên Nguyên-Pascal
Diabetes, Obesity & Metabolism. 2026-08-01 - Low-Dose Antithymocyte Globulin in Type 1 Diabetes: Real-World Exploratory Observation of C-Peptide by Modified Quantitative Response (mQR).David Weber, Joshua Modeste, Sarah Peeling, Timothy P Foster, Brittany S Bruggeman
Diabetes Care. 2026-07-01
Journal Articles
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 DiabetesTeresa Quattrin, Michael J Haller, Andrea K Steck, Eric I Felner, The New England Journal of Medicine
Press Mentions
UF, Google Announce Partnership to Expand Program Studying Diabetes TreatmentsAugust 14th, 2026
CDC Panel Drops Universal COVID-19 Vaccine Recommendation. What It Means for FloridaSeptember 19th, 2025
MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy at American Diabetes AssociationJuly 23rd, 2025
Grant Support
- Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetesUNIVERSITY OF FLORIDA2020–2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








